Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
Eur J Surg Oncol
    December 2017
  1. DESJARDIN M, Desolneux G, Brouste V, Degrandi O, et al
    Parenchymal sparing surgery for colorectal liver metastases: The need for a common definition.
    Eur J Surg Oncol. 2017;43:2285-2291.
    >> Share

  2. CHAPELLE T, Op de Beeck B, Driessen A, Roeyen G, et al
    Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores.
    Eur J Surg Oncol. 2017;43:2277-2284.
    >> Share

    November 2017
  3. REHA J, Mukkamalla SKR, Rathore R, Somasundar PS, et al
    Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base.
    Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30966.
    >> Share

  4. VAN EDEN WJ, Kok NFM, Woensdregt K, Huitema ADR, et al
    Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
    Eur J Surg Oncol. 2017 Nov 15. pii: S0748-7983(17)30956.
    >> Share

  5. OFFERMANS T, Vogelaar FJ, Aquarius M, Janssen-Heijnen MLG, et al
    Preoperative segmental localization of colorectal carcinoma: CT colonography vs. optical colonoscopy.
    Eur J Surg Oncol. 2017;43:2105-2111.
    >> Share

  6. YOUNG CJ, Zahid A, Choy I, Thompson JF, et al
    Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
    Eur J Surg Oncol. 2017;43:2163-2169.
    >> Share

  7. SIDDIQUI MRS, Shanmuganandan AP, Rasheed S, Tekkis P, et al
    An audit comparing the reporting of staging MRI scans for rectal cancer with the London Cancer Alliance (LCA) guidelines.
    Eur J Surg Oncol. 2017;43:2093-2104.
    >> Share

  8. GASH KJ, Baser O, Kiran RP
    Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes.
    Eur J Surg Oncol. 2017;43:2052-2059.
    >> Share

  9. HELDENS AFJM, Bongers BC, Lenssen AF, Stassen LPS, et al
    The association between performance parameters of physical fitness and postoperative outcomes in patients undergoing colorectal surgery: An evaluation of care data.
    Eur J Surg Oncol. 2017;43:2084-2092.
    >> Share

  10. LEE SH, Lee JL, Kim CW, Lee HI, et al
    Oncologic significance of para-aortic lymph node and inferior mesenteric lymph node metastasis in sigmoid and rectal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:2076-2083.
    >> Share

  11. PETZ W, Ribero D, Bertani E, Borin S, et al
    Suprapubic approach for robotic complete mesocolic excision in right colectomy: Oncologic safety and short-term outcomes of an original technique.
    Eur J Surg Oncol. 2017;43:2060-2066.
    >> Share

    October 2017
  12. DUPRE A, Jones RP, Diaz-Nieto R, Fenwick SW, et al
    Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Eur J Surg Oncol. 2017;43:1901-1907.
    >> Share

  13. SUN Y, Xu Z, Lin H, Lu X, et al
    Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Eur J Surg Oncol. 2017;43:1828-1834.
    >> Share

  14. JONKER FHW, Hagemans JAW, Verhoef C, Burger JWA, et al
    The impact of hospital volume on perioperative outcomes of rectal cancer.
    Eur J Surg Oncol. 2017;43:1894-1900.
    >> Share

  15. KVERNENG HULTBERG D, Angenete E, Lydrup ML, Rutegard J, et al
    Nonsteroidal anti-inflammatory drugs and the risk of anastomotic leakage after anterior resection for rectal cancer.
    Eur J Surg Oncol. 2017;43:1908-1914.
    >> Share

  16. SOLON JG, O'Neill M, Chang KH, Deady S, et al
    An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland.
    Eur J Surg Oncol. 2017;43:1924-1931.
    >> Share

    September 2017
  17. DUWE G, Knitter S, Pesthy S, Beierle AS, et al
    Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection.
    Eur J Surg Oncol. 2017;43:1668-1681.
    >> Share

    August 2017
  18. BIN TRAIKI TA, Fisher OM, Valle SJ, Parikh RN, et al
    Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis.
    Eur J Surg Oncol. 2017 Aug 31. pii: S0748-7983(17)30639.
    >> Share

  19. CURRIE AC, Brigic A, Thomas-Gibson S, Suzuki N, et al
    A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer.
    Eur J Surg Oncol. 2017 Aug 23. pii: S0748-7983(17)30643.
    >> Share

  20. POSTON G, Adam R, Xu J, Byrne B, et al
    The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.
    Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30605.
    >> Share

  21. RIZZO G, Zaccone G, Magnocavallo M, Mattana C, et al
    Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer.
    Eur J Surg Oncol. 2017;43:1488-1493.
    >> Share

  22. LORENZON L, Parini D, Rega D, Mellano A, et al
    Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO).
    Eur J Surg Oncol. 2017;43:1472-1480.
    >> Share

  23. HANDGRAAF HJM, Boogerd LSF, Hoppener DJ, Peloso A, et al
    Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis.
    Eur J Surg Oncol. 2017;43:1463-1471.
    >> Share

  24. ZHANG Y, Sun Y, Xu Z, Chi P, et al
    Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
    Eur J Surg Oncol. 2017;43:1440-1446.
    >> Share

    July 2017
  25. DE FELICE F, Magnante AL, Musio D, Ciolina M, et al
    Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Eur J Surg Oncol. 2017;43:1324-1329.
    >> Share

  26. BAUKLOH JK, Reeh M, Spinoglio G, Corratti A, et al
    Evaluation of the robotic approach concerning pitfalls in rectal surgery.
    Eur J Surg Oncol. 2017;43:1304-1311.
    >> Share

    June 2017
  27. KARIM S, Nanji S, Brennan K, Pramesh CS, et al
    Chemotherapy for resected colorectal cancer pulmonary metastases: Utilization and outcomes in routine clinical practice.
    Eur J Surg Oncol. 2017 Jun 1. pii: S0748-7983(17)30480.
    >> Share

  28. HUBNER M, Grass F, Teixeira-Farinha H, Pache B, et al
    Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects.
    Eur J Surg Oncol. 2017;43:1102-1109.
    >> Share

  29. DELHORME JB, Sattler L, Severac F, Triki E, et al
    Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: Toward routine preoperative dosage of Von Willebrand factor?
    Eur J Surg Oncol. 2017;43:1095-1101.
    >> Share

    May 2017
  30. VAN DEN HEIJKANT F, Vermeer TA, Vrijhof EJEJ, Nieuwenhuijzen GAP, et al
    Psoas hitch ureteral reimplantation after surgery for locally advanced and locally recurrent colorectal cancer: Complications and oncological outcome.
    Eur J Surg Oncol. 2017 May 26. pii: S0748-7983(17)30501.
    >> Share

  31. LIBERALE G, Bourgeois P, Larsimont D, Moreau M, et al
    Indocyanine green fluorescence-guided surgery after IV injection in metastatic colorectal cancer: A systematic review.
    Eur J Surg Oncol. 2017 May 8. pii: S0748-7983(17)30457.
    >> Share

  32. FLEMMING JA, Nanji S, Wei X, Webber C, et al
    Association between the time to surgery and survival among patients with colon cancer: A population-based study.
    Eur J Surg Oncol. 2017 May 6. pii: S0748-7983(17)30456.
    >> Share

  33. SLOOTHAAK DAM, van der Linden RLA, van de Velde CJH, Bemelman WA, et al
    Prognostic implications of occult nodal tumour cells in stage I and II colon cancer: The correlation between micrometastasis and disease recurrence.
    Eur J Surg Oncol. 2017 May 5. pii: S0748-7983(17)30454.
    >> Share

  34. ASKLID D, Segelman J, Gedda C, Hjern F, et al
    The impact of perioperative fluid therapy on short-term outcomes and 5-year survival among patients undergoing colorectal cancer surgery - A prospective cohort study within an ERAS protocol.
    Eur J Surg Oncol. 2017 May 3. pii: S0748-7983(17)30445.
    >> Share

  35. JONES RP, Brudvik KW, Franklin JM, Poston GJ, et al
    Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.
    Eur J Surg Oncol. 2017;43:875-883.
    >> Share

    April 2017
  36. KESHAVA HB, Rosen JE, DeLuzio MR, Kim AW, et al
    "What if I do nothing?" The natural history of operable cancer of the alimentary tract.
    Eur J Surg Oncol. 2017;43:788-795.
    >> Share

  37. FRUHLING P, Nilsson A, Duraj F, Haglund U, et al
    Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Eur J Surg Oncol. 2017;43:751-757.
    >> Share

    Reply to: Microwave thermosphere ablation in the multimodal management of colorectal cancer liver metastasis'.
    Eur J Surg Oncol. 2017 Apr 1. pii: S0748-7983(17)30434.
    >> Share

    March 2017
  39. PIARDI T, Chetboun M, Sommacale D, Kianmanesh R, et al
    Microwave Thermosphere ablation in the multimodal management of colorectal cancer liver metastasis.
    Eur J Surg Oncol. 2017 Mar 24. pii: S0748-7983(17)30429.
    >> Share

  40. PUCCIARELLI S, Zorzi M, Gennaro N, Gagliardi G, et al
    In-hospital mortality, 30-day readmission, and length of hospital stay after surgery for primary colorectal cancer: A national population-based study.
    Eur J Surg Oncol. 2017 Mar 16. pii: S0748-7983(17)30369.
    >> Share

  41. GIETELINK L, Wouters MW, Marijnen CA, van Groningen J, et al
    Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
    Eur J Surg Oncol. 2017 Mar 10. pii: S0748-7983(17)30366.
    >> Share

    February 2017
  42. FLOODEEN H, Hallbook O, Hagberg LA, Matthiessen P, et al
    Costs and resource use following defunctioning stoma in low anterior resection for cancer - A long-term analysis of a randomized multicenter trial.
    Eur J Surg Oncol. 2017;43:330-336.
    >> Share

  43. ARROYAVE MC, DeLacy FB, Lacy AM
    Transanal total mesorectal excision (TaTME) for rectal cancer: Step by step description of the surgical technique for a two-teams approach.
    Eur J Surg Oncol. 2017;43:502-505.
    >> Share

    January 2017
  44. YAMASHITA S, Odisio BC, Huang SY, Kopetz SE, et al
    Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
    Eur J Surg Oncol. 2017 Jan 29. pii: S0748-7983(17)30057.
    >> Share

  45. DENOST Q, Kontovounisios C, Rasheed S, Chevalier R, et al
    Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
    Eur J Surg Oncol. 2017;43:92-99.
    >> Share

  46. SUN Y, Chi P, Lin H, Lu X, et al
    Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact.
    Eur J Surg Oncol. 2017;43:85-91.
    >> Share

  47. OLTHOF PB, Huiskens J, Schulte NR, Wicherts DA, et al
    Hepatic vascular inflow occlusion is associated with reduced disease free survival following resection of colorectal liver metastases.
    Eur J Surg Oncol. 2017;43:100-106.
    >> Share

  48. HOLMAN FA, Bosman SJ, Haddock MG, Gunderson LL, et al
    Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.
    Eur J Surg Oncol. 2017;43:107-117.
    >> Share

    December 2016
  49. NANJI S, Tsang ME, Wei X, Booth CM, et al
    Regional lymph node involvement in patients undergoing liver resection for colorectal cancer metastases.
    Eur J Surg Oncol. 2016 Dec 13. pii: S0748-7983(16)31035.
    >> Share

  50. XU W, Xu Z, Cheng H, Ying J, et al
    Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.
    Eur J Surg Oncol. 2016;42:1841-1850.
    >> Share

  51. MANCHON-WALSH P, Aliste L, Espinas JA, Prades J, et al
    Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.
    Eur J Surg Oncol. 2016;42:1873-1880.
    >> Share

    November 2016
  52. MONASTYRSKA E, Hagner W, Jankowski M, Glowacka I, et al
    Prospective assessment of the quality of life in patients treated surgically for rectal cancer with lower anterior resection and abdominoperineal resection.
    Eur J Surg Oncol. 2016;42:1647-1653.
    >> Share

  53. ELLIOT AH, Martling A, Glimelius B, Johansson H, et al
    Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer.
    Eur J Surg Oncol. 2016;42:1667-1673.
    >> Share

  54. HASEGAWA S, Takahashi R, Hida K, Kawada K, et al
    Revisiting the treatment strategy for rectal cancer through the pattern of local recurrence.
    Eur J Surg Oncol. 2016;42:1674-1679.
    >> Share

  55. ALAMRI Y, Buchwald P, Dixon L, Dobbs B, et al
    Salvage surgery in patients with recurrent or residual squamous cell carcinoma of the anus.
    Eur J Surg Oncol. 2016;42:1687-1692.
    >> Share

    October 2016
  56. GHANIPOUR L, Jirstrom K, Sundstrom M, Glimelius B, et al
    Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer.
    Eur J Surg Oncol. 2016 Oct 31. pii: S0748-7983(16)30951.
    >> Share

  57. LEUNG V, Huo YR, Liauw W, Morris DL, et al
    Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
    Eur J Surg Oncol. 2016 Oct 13. pii: S0748-7983(16)30929.
    >> Share

  58. LORIMIER G, Linot B, Paillocher N, Dupoiron D, et al
    Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Eur J Surg Oncol. 2016 Oct 7. pii: S0748-7983(16)30899.
    >> Share

  59. MACIVER AH, Lee N, Skitzki JJ, Boland PM, et al
    Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms.
    Eur J Surg Oncol. 2016 Oct 3. pii: S0748-7983(16)30901.
    >> Share

    September 2016
  60. KRISHNAMURTHY A, Kankesan J, Wei X, Nanji S, et al
    Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
    Eur J Surg Oncol. 2016 Sep 17. pii: S0748-7983(16)30888.
    >> Share

    August 2016
  61. WIELDRAAIJER T, Duineveld LA, van Asselt KM, van Geloven AA, et al
    Follow-up of colon cancer patients; causes of distress and need for supportive care: Results from the ICARE Cohort Study.
    Eur J Surg Oncol. 2016 Aug 31. pii: S0748-7983(16)30856.
    >> Share

  62. JONES RP, Malik HZ, Fenwick SW, Terlizzo M, et al
    PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Eur J Surg Oncol. 2016 Aug 10. pii: S0748-7983(16)30837.
    >> Share

    July 2016
  63. KENNELLY RP, Gryfe R, Winter DC
    Familial colorectal cancer: Patient assessment, surveillance and surgical management.
    Eur J Surg Oncol. 2016 Jul 27. pii: S0748-7983(16)30675.
    >> Share

    June 2016
  64. MARGADANT CC, Bruns ER, Sloothaak DA, van Duijvendijk P, et al
    Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer.
    Eur J Surg Oncol. 2016 Jun 23. pii: S0748-7983(16)30592.
    >> Share

  65. KOHNE CH, Poston G, Folprecht G, Ciardiello F, et al
    FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study.
    Eur J Surg Oncol. 2016 Jun 23. pii: S0748-7983(16)30587.
    >> Share

  66. MOHAN HM, Ryan E, Balasubramanian I, Kennelly R, et al
    Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
    Eur J Surg Oncol. 2016 Jun 22. pii: S0748-7983(16)30164.
    >> Share

  67. CHOLANKERIL G, Hu M, Tanner E, Cholankeril R, et al
    Skilled nursing facility placement in hospitalized elderly patients with colon cancer.
    Eur J Surg Oncol. 2016 Jun 17. pii: S0748-7983(16)30199.
    >> Share

  68. REIMA H, Saar H, Innos K, Soplepmann J, et al
    Methylene blue intra-arterial staining of resected colorectal cancer specimens improves accuracy of nodal staging: A randomized controlled trial.
    Eur J Surg Oncol. 2016 Jun 16. pii: S0748-7983(16)30187.
    >> Share

    May 2016
  69. RIBEIRO GOMES J, Belotto M, D'Alpino Peixoto R
    The role of surgery for unusual sites of metastases from colorectal cancer: A review of the literature.
    Eur J Surg Oncol. 2016 May 30. pii: S0748-7983(16)30170.
    >> Share

  70. PIEGELER T, Beck-Schimmer B
    Anesthesia and colorectal cancer - The perioperative period as a window of opportunity?
    Eur J Surg Oncol. 2016 May 24. pii: S0748-7983(16)30154.
    >> Share

  71. MONTRONI I, Wexner SD
    Robotic colorectal cancer surgery: Are data supporting the desire to innovate?
    Eur J Surg Oncol. 2016 May 21. pii: S0748-7983(16)30152.
    >> Share

  72. MARTINS J, Alexandrino H, Oliveira R, Cipriano MA, et al
    Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
    Eur J Surg Oncol. 2016;42:713-21.
    >> Share

    April 2016
  73. GERVAZ P, Usel M, Rapiti E, Chappuis P, et al
    Right colon cancer: Left behind.
    Eur J Surg Oncol. 2016 Apr 23. pii: S0748-7983(16)30057.
    >> Share

  74. THILLAI K, Repana D, Korantzis I, Kane P, et al
    Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30049.
    >> Share

  75. PEDZIWIATR M, Pisarska M, Major P, Grochowska A, et al
    Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30055.
    >> Share

  76. VAN AMERONGEN MJ, van der Stok EP, Futterer JJ, Jenniskens SF, et al
    Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.
    Eur J Surg Oncol. 2016;42:523-30.
    >> Share

  77. LYKKE J, Jess P, Roikjaer O
    The prognostic value of lymph node ratio in a national cohort of rectal cancer patients.
    Eur J Surg Oncol. 2016;42:504-12.
    >> Share

  78. BJORNSSON B, Sparrelid E, Rosok B, Pomianowska E, et al
    Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.
    Eur J Surg Oncol. 2016;42:531-7.
    >> Share

    March 2016
  79. WIGGANS MG, Shahtahmassebi G, Aroori S, Bowles MJ, et al
    The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Eur J Surg Oncol. 2016;42:426-32.
    >> Share

    February 2016
  80. TANIS E, Spliethoff JW, Evers DJ, Langhout GC, et al
    Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy.
    Eur J Surg Oncol. 2016;42:251-9.
    >> Share

  81. GHIGNONE F, van Leeuwen BL, Montroni I, Huisman MG, et al
    The assessment and management of older cancer patients: A SIOG surgical task force survey on surgeons' attitudes.
    Eur J Surg Oncol. 2016;42:297-302.
    >> Share

  82. LLADO L, Munoz A, Ramos E, Torras J, et al
    The anterior hanging-approach improves postoperative course after right hepatectomy in patients with colorectal liver metastases. Results of a prospective study with propensity-score matching comparison.
    Eur J Surg Oncol. 2016;42:176-83.
    >> Share

  83. TAKATSUKI M, Tokunaga S, Uchida S, Sakoda M, et al
    Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
    Eur J Surg Oncol. 2016;42:184-9.
    >> Share

  84. VERMEER TA, Orsini RG, Nieuwenhuijzen GA, Rutten HJ, et al
    Stoma placement in obstructive rectal cancer prior to neo-adjuvant treatment and definitive surgery: A practical guideline.
    Eur J Surg Oncol. 2016;42:273-80.
    >> Share

  85. RUPINSKI M, Szczepkowski M, Malinowska M, Mroz A, et al
    Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign.
    Eur J Surg Oncol. 2016;42:288-96.
    >> Share

  86. KUIJPERS AM, Hauptmann M, Aalbers AG, Nienhuijs SW, et al
    Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed.
    Eur J Surg Oncol. 2016;42:244-50.
    >> Share

  87. BOUHADJARI N, Gabato W, Calabrese D, Msika S, et al
    Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
    Eur J Surg Oncol. 2016;42:219-23.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016